Ureterolithiasis (Stone in Ureter) in Dogs

The presence of stones, or calculi, within the urinary tract is a common affliction in veterinary medicine, typically manifesting as bladder stones (cystolithiasis) or kidney stones (nephrolithiasis). However, when a stone migrates from the kidney and becomes lodged in the ureter—the narrow tube connecting the kidney to the bladder—the condition is known as Ureterolithiasis. This seemingly small anatomical obstruction represents one of the most serious and life-threatening urological emergencies in canine practice.

Ureterolithiasis causes an immediate and often complete obstruction of urine flow from the affected kidney. If the obstruction is unilateral and the other kidney is healthy, the initial signs may be subtle. However, if the obstruction is bilateral, or if the contralateral kidney is already compromised (which is frequently the case in stone-forming dogs), the blockage rapidly leads to post-renal azotemia, kidney damage (hydronephrosis), and potentially acute kidney injury (AKI) and death if not addressed urgently.

This comprehensive guide delves into the intricate causes, clinical presentation, advanced diagnostic techniques, modern treatment modalities, and crucial preventative strategies associated with ureterolithiasis in the canine patient.

I. Pathophysiology and Efficacy of Stone Formation

Ureteral stones are almost always nephroliths (stones formed in the kidney pelvis) that have subsequently migrated down the ureter. Because the ureter is exceedingly narrow—a mere 1 to 3 millimeters in diameter in most dogs—even a small calculus can cause a complete blockage.

A. The Mechanism of Obstruction and Damage

When the stone lodges, the pressure of the continuously produced urine backs up into the kidney pelvis, leading to two major consequences:

1. Hydroureter and Hydronephrosis: The ureter dilates (hydroureter), and the kidney pelvis expands dramatically (hydronephrosis). This increased pressure inside the kidney eventually crushes the delicate functional tissue (the parenchyma and medullary segments), leading to irreversible loss of nephron function, scarring, and permanent reduction in glomerular filtration rate (GFR).
2. Post-Renal Azotemia: The inability to excrete waste products (urea and creatinine) leads to their systemic accumulation, causing toxic effects throughout the body and metabolic derangement.

B. Causes and Stone Composition

The formation of uroliths is complex, involving supersaturation of urine with minerals, changes in urinary pH, and the lack of natural crystallization inhibitors. In dogs, four major types of ureteral stones are recognized:

1. Calcium Oxalate (CaOx)

• Prevalence: The most common stone type found in the upper urinary tract (kidney/ureter) of dogs.
• Formation: CaOx stones thrive in neutral to acidic urine. Key risk factors include hypercalciuria (excess calcium excretion), hypophosphatemia, and chronic metabolic acidosis. They are often associated with systemic conditions like hyperadrenocorticism (Cushing’s disease) or primary hyperparathyroidism, which elevate systemic calcium levels.
• Key Feature: These stones are extremely hard, highly radiopaque, and cannot be medically dissolved.

2. Struvite (Magnesium Ammonium Phosphate)

• Prevalence: Very common overall, but less common than CaOx in the ureter.
• Formation: Almost always linked to infection by urease-producing bacteria (e.g., Staphylococcus, Proteus). Urease breaks down urea into ammonia, dramatically raising urine pH (alkaline) and creating the perfect environment for Struvite crystal precipitation.
• Key Feature: Unlike CaOx, small Struvite stones can be medically dissolved if they are still located in the bladder or renal pelvis, but dissolution is risky and generally ineffective once the stone is tightly lodged in the narrow ureter.

3. Urate (Ammonium Acid Urate)

• Prevalence: Highly associated with breeds having specific metabolic defects.
• Formation: Caused by defective uric acid metabolism, often due to a genetic defect in the hepatic uptake of urate (in the case of the Dalmatian). Found in acidic urine.
• Key Feature: These stones are characteristically less radiopaque (sometimes radiolucent) and require specific low-purine diets and medications (Allopurinol) for management.

4. Cystine

• Prevalence: Less common, tied exclusively to inherited tubular transport defects.
• Formation: A deficiency in the transport mechanisms within the renal tubules leads to high concentrations of the amino acid cystine in the urine. Found primarily in acidic urine.
• Key Feature: Management involves both dietary modification and specific medications (e.g., thiol-binding drugs) to increase the solubility of cystine.

II. Signs and Symptoms: An Emergency Presentation

The clinical signs of ureterolithiasis depend heavily on the severity and completeness of the obstruction, whether the obstruction is unilateral or bilateral, and the pre-existing health of the kidneys.

A. Silent Disease (Unilateral, Partial Obstruction)

In cases where only one ureter is partially blocked, the dog may be asymptomatic or show only vague, intermittent signs:

• Mild, intermittent flank pain or abdominal discomfort.
• Subtle hematuria (blood in urine) or crystalluria.
• Recurrent, unexplained lethargy or decreased appetite (anorexia).

B. Acute Crisis (Complete or Bilateral Obstruction)

This is the life-threatening presentation, where signs reflect rapid onset of severe kidney failure and uremia:

III. Dog Breeds at Risk (Genetic Predisposition)

Urolithiasis is a highly breed-dependent condition, particularly for Calcium Oxalate, Urate, and Cystine stones. Genetic factors often dictate the composition of the urolith, thus influencing the risk of ureterolithiasis.

1. Miniature Schnauzer

The Miniature Schnauzer is disproportionately prone to Calcium Oxalate stone formation. This susceptibility is believed to be linked to a familial defect causing hypercalciuria (excessive calcium excretion in the urine) or a defect in renal tubular function. They are also prone to hyperlipidemia, which may contribute to systemic metabolic imbalances that enhance crystal formation. These factors combine to make them highly susceptible to both nephroliths and subsequently, ureterolithiasis.

2. Lhasa Apso and Shih Tzu

These Asian breeds also exhibit a high predisposition to Calcium Oxalate stones. Similar to the Schnauzer, this is likely multifactorial, including genetic hypercalciuria and possibly structural abnormalities in their urinary tracts that predispose them to developing and harboring stones in the kidney pelvis before migration. They often require lifelong surveillance due to high recurrence rates.

3. Yorkshire Terrier and Bichon Frise

These small breeds are also categorized as high-risk for Calcium Oxalate calculi. Their small body size means their ureters are exceptionally narrow, making even tiny migrated stones more likely to cause complete and catastrophic obstruction. Genetic studies suggest a familial component in their crystal formation tendencies.

4. Dalmatian

Dalmatians are the classic example of breed-specific urolithiasis, suffering almost exclusively from Urate stones. They possess a unique genetic mutation (in the SLC2A9 gene) that impairs the liver’s ability to efficiently transport uric acid, leading to excessively high concentrations of uric acid precursors in the urine (hyperuricosuria). While most urate stones form in the bladder, they are also prone to nephroliths that can migrate and cause life-threatening ureteral obstruction.

5. English Bulldog

Bulldogs also show a high prevalence of Urate stones, though often less severe than Dalmatians. They also carry a high risk for Cystine and occasionally Struvite stones, demonstrating a complex genetic predisposition to multiple forms of urolithiasis, thus putting them at chronic risk of ureteral stone migration.

6. Newfoundland, Labrador Retriever, and Dachshund

These breeds have a known, sex-linked predisposition to Cystine stones, which are caused by a failure of the renal tubules to reabsorb adequate amounts of the amino acids cystine, ornithine, lysine, and arginine (COLA). As these dogs accumulate cystine in their urine, they are continuously at risk for stone formation in the kidneys and subsequent ureteral blockage.

IV. Age Affected

Urolithiasis is not strictly limited by age, but the risk profile shifts based on stone type:

• Puppies and Young Adults (under 3 years): Cystine stones and some genetically linked Urate stones (Dalmatians) can manifest early in life due to inherent metabolic defects.
• Adult and Older Dogs (4 years and up): This is the highest risk group. Calcium Oxalate stones tend to peak in middle-aged to senior dogs, often coinciding with the onset of endocrine diseases (like Cushing’s) or chronic kidney function decline. Struvite stones are seen at any age but correlate with exposure to bacterial urinary tract infections.

V. Diagnosis: Confirming Obstruction and Location

Diagnosis of ureterolithiasis requires rapid, precise identification of the stone’s location, the degree of obstruction, and the functional status of the affected kidney.

A. Laboratory Diagnostics

1. Complete Blood Count (CBC) and Biochemical Profile:
   • Azotemia: Elevated Blood Urea Nitrogen (BUN) and Creatinine are the hallmarks of post-renal obstruction. This may be severe in bilateral cases.
   • Electrolyte Imbalances: Hyperkalemia (high potassium) is a critical emergency finding that can lead to cardiac arrhythmias. Hyperphosphatemia and often metabolic acidosis are also present.
   • Calcium: Hypercalcemia is a critical finding, strongly suggesting a predisposition to Calcium Oxalate stones or an underlying primary hyperparathyroidism.
2. Urinalysis (UA) and Culture:
   • Specific Gravity: May be low (isosthenuric) if the kidney is severely damaged and unable to concentrate urine.
   • Crystalluria: Identification of specific crystals (e.g., Calcium Oxalate dihydrate, Struvite) supports the stone type diagnosis but does not confirm the cause of the obstruction.
   • Infection: A urine culture is vital to rule out concurrent pyelonephritis (kidney infection) or bacterial involvement (critical for Struvite stones).

B. Imaging Diagnostics

Imaging is essential to confirm the presence of stones and the resultant damage (hydronephrosis).

1. Abdominal Radiography (X-rays):
   • Most ureteral stones (Struvite, Calcium Oxalate) are radiopaque (visible).
   • Limitation: Small stones can be obscured by overlying bowel gas, and Urate or Cystine stones may be radiolucent (invisible). It also cannot reliably confirm if the ureter is truly obstructed or merely dilated.
2. Abdominal Ultrasonography:
   • Superiority: Ultrasound is the primary modality for confirming obstruction. It visualizes the stones in the ureter, the dilation of the ureter (hydroureter), and the crucial secondary finding of hydronephrosis (dilation of the renal pelvis).
   • Assessment: Doppler flow assessment can sometimes be used to gauge renal perfusion and viability.
3. Excretory Urography (Intravenous Pyelogram – IVP) or Computed Tomography (CT):
   • Gold Standard: These contrast studies are often necessary before surgery. Contrast dye is injected and excreted by the functional kidneys.
   • Confirmation: If contrast dye stops abruptly at the level of the stone, obstruction is confirmed.
   • Assessment of Function: IVP/CT reveals the degree to which the affected kidney is still functional. If the kidney fails to fill with contrast even after several hours, it indicates severe, irreversible damage (a non-functional kidney). This dictates the surgical approach (attempted salvage vs. nephrectomy).

VI. Treatment: Managing the Acute Obstruction

Ureteral obstruction is a medical emergency requiring rapid intervention. While stabilization of the patient is the immediate priority, permanent removal of the obstruction is almost always necessary to prevent irreversible kidney damage.

A. Initial Stabilization (Medical Management)

Before any procedure, the patient must be stabilized, focusing on reducing systemic toxicity:

1. Aggressive Fluid Therapy: Intravenous fluids are mandatory to correct dehydration and encourage post-obstructive diuresis.
2. Electrolyte Correction: Immediate treatment of life-threatening hyperkalemia (using dextrose, insulin, or calcium gluconate) is required to stabilize the heart.
3. Pain Management: Opioids (e.g., Fentanyl, Morphine) are used for severe abdominal and flank pain. Non-steroidal anti-inflammatories (NSAIDs) are contraindicated until renal function is restored.
4. Antibiotics: Broad-spectrum antibiotics are initiated immediately if infection (pyelonephritis) is suspected or confirmed.

Note: Medical dissolution (diet and medication) is rarely effective for ureteral stones because the stone is tightly impacted, preventing therapeutic agents from reaching its surface. Aggressive medical flushing risks dislodging the stone further down, potentially causing rupture.

B. Surgical and Interventional Procedures (Definitive Treatment)

In the past, the only option was surgical removal (ureterotomy), which carries a high risk of postoperative stricture formation and leakage. Modern veterinary medicine now favors less invasive, more reliable methods.

1. Ureterotomy (Traditional Surgery)

• Procedure: Open abdominal surgery where the ureter is incised longitudinally to remove the stone.
• Complications: High risk (up to 50%) of life-threatening complications, primarily due to the tiny size of the ureter leading to stricture (scarring and future blockage) or urine leakage (uroabdomen). This procedure is now largely superseded by interventional radiology techniques.

2. Ureteral Stenting

• Procedure: A thin, flexible tube (stent) is placed endoscopically or surgically within the ureter, bridging the gap between the kidney and the bladder. The stent holds the ureter open, bypasses the stone, and allows urine to flow around the blockage.
• Benefit: Allows time for the kidney to recover function without the high complication rate of cutting the ureter.
• Limitation: Requires lifelong maintenance and monitoring for stent complications (migration, blockage).

3. Subcutaneous Ureteral Bypass (SUB) System

• Gold Standard Intervention: This is the preferred method for managing malignant or complex ureteral obstructions in specialized centers.
• Mechanism: The SUB system is a permanent, two-part device. One catheter is inserted into the renal pelvis, and a second catheter is inserted into the bladder. These catheters are connected externally via a port placed under the skin (subcutaneously).
• Function: This system completely bypasses the entire damaged ureter, establishing a reliable, high-flow route for urine directly from the kidney to the bladder.
• Maintenance: The external port allows for routine flushing (typically every 3–6 months) to prevent mineral clogging and bacterial adherence. While complex, it offers the best long-term patency (openness) and functional outcome for a salvable kidney.

4. Nephrectomy

• If the affected kidney is found to be non-functional (e.g., complete loss of GFR, severe chronic changes, or overwhelming irreversible hydronephrosis), and the opposite kidney is healthy, surgical removal of the kidney (Nephrectomy) is the safest course of action. This removes the source of infection and pain and eliminates the future risk of obstruction from that side.

VII. Prognosis & Complications

A. Prognosis

The prognosis for canine ureterolithiasis is guarded to fair, highly dependent on three critical factors:

1. Duration of Obstruction: If the obstruction is relieved within 3–4 days, the affected kidney has a good chance (approx. 70–80%) of recovering significant function. If the blockage lasts longer than 7–10 days, irreversible damage is likely, and the long-term prognosis is poor for that specific kidney.
2. Status of the Contralateral Kidney: If the dog has bilateral disease or pre-existing chronic kidney disease (CKD) in the other kidney, the prognosis is poor unless immediate, successful intervention is achieved.
3. Underlying Stone Type: Dogs with genetically driven stones (CaOx, Urate, Cystine) face a guarded long-term prognosis due to the extremely high rate of stone recurrence.

B. Complications

1. Acute Kidney Injury (AKI): Rapid deterioration of renal function secondary to the obstruction.
2. Pyelonephritis: Severe infection of the kidney, often ascending from the ureter.
3. Ureteral Stricture: Scarring and narrowing of the ureter following ureterotomy, leading to re-obstruction.
4. Uroabdomen: Leakage of urine into the abdominal cavity, a life-threatening complication of surgical repair or ureteral rupture.
5. Recurrence: The most common long-term complication; dogs who form one stone type are highly likely to form others, requiring lifelong surveillance and management.
6. SUB System Complications: Requires maintenance flushing; potential for catheter migration or blockage if maintenance is neglected.

VIII. Prevention: Lifelong Management

Prevention is centered on two principles: correcting the underlying metabolic anomaly and decreasing the concentration of crystallizing compounds in the urine.

1. Stone Analysis: Every stone, whether removed surgically or passed, must be analyzed by a specialized laboratory (e.g., the Minnesota Urolith Center) to determine composition, as prevention protocols are stone-specific.
2. Control Underlying Disease: Treat systemic conditions like hypercalcemia, hyperadrenocorticism, or chronic bacterial infections.
3. Aggressive Monitoring: Dogs at high risk require repeat urinalysis, blood profiles, and abdominal imaging (ultrasound or X-ray) every 3–6 months to catch new stone formation or recurrence before migration occurs.

IX. Diet and Nutrition: Tailored Therapeutic Strategies

Diet is the cornerstone of prevention, primarily aimed at altering urine pH, reducing stone-forming elements, and promoting diuresis.

A. Non-Specific Strategies (General Urinary Health)

• Hydration is Paramount: The most important step is increasing urine volume to dilute crystalloids. This is achieved by feeding wet (canned) food exclusively and ensuring constant access to fresh water.
• Canned Prescription Diets: Even when fed the appropriate prescription diet, feeding the canned version significantly improves outcomes compared to dry kibble.

B. Stone-Specific Dietary Protocols

1. Calcium Oxalate Prevention

• Goal: Promote neutral to alkaline urine (pH 6.5–7.5) and reduce calcium and oxalate excretion.
• Dietary Focus: Diets that minimize animal protein (which promotes acidic urine and hypercalciuria), low in sodium, and moderate in fat. Potassium citrate supplementation is often required to alkalinize the urine.
• Examples: Hill’s Prescription Diet u/d, Purina Pro Plan Veterinary Diets UR, Royal Canin Veterinary Diet Urinary SO Oxalate.
• Avoid: High-oxalate foods (spinach, peanuts, sweet potatoes, vitamin C supplements).

2. Struvite Prevention

• Goal: Promote acidic urine (pH 5.5–6.5) and restrict magnesium, phosphorus, and protein.
• Dietary Focus: Highly restricted diets designed for dissolution (e.g., Hill’s s/d) are used short-term. For long-term prevention, less restrictive diets (e.g., c/d Multicare) are used to maintain an acidic pH and low mineral concentration.
• Crucial Note: Struvite prevention requires meticulous control of Urinary Tract Infections (UTIs).

3. Urate Prevention (Dalmatians, Bulldogs)

• Goal: Promote alkaline urine and severely restrict purine intake (precursor to uric acid).
• Dietary Focus: Low-purine diets (often those that are vegetable-based or contain novel proteins like egg), combined with the medication Allopurinol to inhibit uric acid production.
• Examples: Usually Hill’s u/d (which is low protein and low purine) or specialized homemade diets formulated by a veterinary nutritionist.

4. Cystine Prevention

• Goal: Promote alkaline urine and use medications to bind cystine.
• Dietary Focus: Moderate protein restriction and high sodium content (to promote fluid intake). Often requires specialized prescription diets and the use of thiol-binding drugs (e.g., Tiopronin, D-penicillamine) to increase cystine solubility.

X. Zoonotic Risk

There is no zoonotic risk associated with canine ureterolithiasis. Ureteral stones are caused by endogenous metabolic defects, genetic predispositions, or species-specific bacterial infections (in the case of Struvite). This condition is confined to the canine patient.

Conclusion

Ureterolithiasis in dogs is a critical condition demanding prompt, specialized veterinary care. While challenging to diagnose prior to the onset of severe clinical signs, the prognosis has significantly improved with the adoption of advanced interventional techniques like the SUB system. Successful long-term management hinges not just on removing the obstruction but on rigorous, lifelong adherence to stone-specific dietary and medical prophylactic protocols. For owners of high-risk breeds, awareness and proactive monitoring are the best defenses against this silent, yet catastrophic, urinary emergency.

#Ureterolithiasis #DogKidneyStones #CanineHealth #VetMed #DogEmergency #UrologyVet #Hydronephrosis #SUBSystem #DogStonePrevention #MiniatureSchnauzer #DalmatianHealth #DogUrinaryTract #PetHealthTips #AskAVet #DogSurgery #UreteralStent #CanineUrolithiasisAwareness